Back to Search
Start Over
Molecular determinants of frequency dependence and Ca2+ potentiation of verapamil block in the pore region of Cav1.2.
- Source :
-
Molecular pharmacology [Mol Pharmacol] 2004 Nov; Vol. 66 (5), pp. 1236-47. Date of Electronic Publication: 2004 Jul 30. - Publication Year :
- 2004
-
Abstract
- Verapamil block of Ca(v)1.2 is frequency-dependent and potentiated by Ca(2+). We examined the molecular determinants of these characteristics using mutations that effect Ca(2+) interactions with Ca(v)1.2. Mutant and wild-type Ca(v)1.2 channels were transiently expressed in tsA 201 cells with beta(1b) and alpha(2)delta subunits. The four conserved glutamates that compose the Ca(2+) selectivity filter in Ca(v)1.2 were mutated to Gln (E363Q, E709Q, E1118Q, E1419Q) and the adjacent conserved threonine in each domain was mutated to Ala (T361A, T707A, T1116A, T1417A). The L-type-specific residues in the domain III pore region (F1117G) and the C-terminal tail (I1627A) were also mutated and assayed for block by verapamil using whole-cell voltage-clamp recordings in 10 mM Ba(2+) or 10 mM Ca(2+). In Ba(2+), none of the pore-region mutations reduced the fraction of current blocked by 30 microM verapamil at 0.05 Hz stimulation. However, all of the pore-region mutations abolished Ca(2+) potentiation of verapamil block at 0.05 Hz. The T1116A, F1117G, E1118Q, and E1419Q mutations all significantly reduced frequency-dependent verapamil block (1-Hz stimulation) in both Ba(2+) and Ca(2+). The I1627A mutation, which disrupts Ca(2+)-dependent inactivation, increased the fraction of closed channels blocked by 30 microM verapamil in Ba(2+) but did not affect frequency-dependent block in Ba(2+) or Ca(2+). Our data suggest that the pore region of domain III may contribute to a high affinity verapamil binding site accessed during 1-Hz stimulation and that Ca(2+) binding to multiple sites may be required for potentiation of verapamil block of closed channels.
- Subjects :
- Alanine genetics
Amino Acid Substitution
Barium pharmacology
Binding Sites
Calcium Channels, L-Type chemistry
Calcium Channels, L-Type genetics
Cells, Cultured
Drug Synergism
Glutamic Acid genetics
Glutamine genetics
Glycine genetics
Humans
Kinetics
Mutation
Permeability drug effects
Phenylalanine genetics
Threonine genetics
Calcium pharmacology
Calcium Channel Blockers pharmacology
Calcium Channels, L-Type metabolism
Verapamil pharmacology
Subjects
Details
- Language :
- English
- ISSN :
- 0026-895X
- Volume :
- 66
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- Molecular pharmacology
- Publication Type :
- Academic Journal
- Accession number :
- 15286207
- Full Text :
- https://doi.org/10.1124/mol.104.000893